Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder
ClinicalTrials.gov study NCT03107026. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
ClinicalTrials.gov study NCT00970268. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Effect of Acceptance and Commitment Therapy on Psychotic Severity
ClinicalTrials.gov study NCT06160869. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01462929. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT01262365. IPD Sharing: Not stated. Countries: 21. Publications: 2.
BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging
ClinicalTrials.gov study NCT05552508. IPD Sharing: YES. Countries: 7. Publications: 1.
Extended Dosing With Eltrombopag for Severe Aplastic Anemia
ClinicalTrials.gov study NCT01891994. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT02914522. IPD Sharing: NO. Countries: 40. Publications: 11.
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
ClinicalTrials.gov study NCT02864953. IPD Sharing: NO. Countries: 24. Publications: 2.
Treatment of Severe Childhood Aggression (The TOSCA Study)
ClinicalTrials.gov study NCT00796302. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)
ClinicalTrials.gov study NCT01854645. IPD Sharing: Not stated. Countries: 3. Publications: 4.
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
ClinicalTrials.gov study NCT05079919. IPD Sharing: YES. Countries: 23. Publications: 2.
Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
ClinicalTrials.gov study NCT03094052. IPD Sharing: YES. Countries: 1. Publications: 10.
A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA B
ClinicalTrials.gov study NCT02755649. IPD Sharing: Not stated. Countries: 10. Publications: 8.
Evaluation of Moderate to Severe Influenza Outcomes in Children
ClinicalTrials.gov study NCT02979626. IPD Sharing: UNDECIDED. Countries: 1. Publications: 11.
Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
ClinicalTrials.gov study NCT00658775. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
ClinicalTrials.gov study NCT01690299. IPD Sharing: YES. Countries: 11. Publications: 3.
The Efficacy and Safety Study of Electro-acupuncture for Severe Chronic Functional Constipation
ClinicalTrials.gov study NCT01726504. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
ClinicalTrials.gov study NCT00574249. IPD Sharing: Not stated. Countries: 15. Publications: 1.
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
ClinicalTrials.gov study NCT03518086. IPD Sharing: YES. Countries: 35. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.